HIGHLIGHTS
- who: Argatroban and collaborators from the Department of Neurology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, and China have published the paper: Using Thrombin Time to Evaluate the Efficacy of Anticoagulant Therapy for Acute Cerebral Infarction, in the Journal: (JOURNAL)
- what: The authors investigated the effectiveness of the intravenous in ischemic stroke patients who cannot be treat with intravenous thrombolysis due to the limited window. This study showed that IV argatroban therapy could prevent recurrence and progression of thrombosis in the infarcted area.
- how: The results indicated that therapy with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.